Clinical trial for Type 1 Diabetes
Official title ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
ClinicalTrials.gov ID: NCT05463289
What this study is testing
- What it's testing
- The study wants to know if using an AI‑driven, non‑dilating eye camera raises the number of underserved youth with diabetes who are screened for diabetic eye disease, and how accurately the AI detects that disease.
- Who it's for
- Underserved children and teens who have type 1 diabetes, type 2 diabetes, or cystic‑fibrosis‑related diabetes.
- What's involved
- Participants will have pictures taken of their retinas with a special camera that does not require eye drops, and the images will be analyzed by autonomous AI software.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 21
You may be able to join if
- Diagnosis of Type 1 diabetes for ≥3 years, and age 11 or in puberty
- Patients with Type 1 or Type 2 diabetes,
- 8-21 years of age with known diabetic retinopathy (true positives).
- No time limit on last diabetic eye exam.
You likely can't join if
- Known diabetic eye exam in the last 12 months
The study team makes the final eligibility decision.
Where it is enrolling
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Baltimore, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.